title: Crucial roles of Nox2-derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle-aged mice.
abstract: OBJECTIVE
  Systemic oxidative stress associated with dietary calorie overload plays an important role in the deterioration of vascular function in middle-aged patients suffering from obesity and insulin resistance. However, effective therapy is still lacking.
  
  
  METHODS
  In this study, we used a mouse model of middle-aged obesity to investigate the therapeutic potential of pharmaceutical inhibition (apocynin, 5 mM supplied in the drinking water) or knockout of Nox2, an enzyme generating reactive oxygen species (ROS), in high-fat diet (HFD)-induced obesity, oxidative stress, insulin resistance and endothelial dysfunction. Littermates of C57BL/6J wild-type (WT) and Nox2 knockout (KO) mice (7 months old) were fed with a HFD (45% kcal fat) or normal chow diet (NCD, 12% kcal fat) for 16 weeks and used at 11 months of age.
  
  
  RESULTS
  Compared to NCD WT mice, HFD WT mice developed obesity, insulin resistance, dyslipidaemia and hypertension. Aortic vessels from these mice showed significantly increased Nox2 expression and ROS production, accompanied by significantly increased ERK1/2 activation, reduced insulin receptor expression, decreased Akt and eNOS phosphorylation and impaired endothelium-dependent vessel relaxation to acetylcholine. All these HFD-induced abnormalities (except the hyperinsulinaemia) were absent in apocynin-treated WT or Nox2 KO mice given the same HFD.
  
  
  CONCLUSIONS
  In conclusion, Nox2-derived ROS played a key role in damaging insulin receptor and endothelial function in dietary obesity after middle-age. Targeting Nox2 could represent a valuable therapeutic strategy in the metabolic syndrome.
authors: Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
authors: Junjie
authors: J
authors: Du
authors: Lampson M
authors: LM
authors: Fan
authors: Anna
authors: A
authors: Mai
authors: Jian-Mei
authors: JM
authors: Li
mesh_terms: D000367:Age Factors; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001011:Aorta / Q000187:drug effects / Q000201:enzymology* / Q000503:physiopathology; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D059305:Diet, High-Fat; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D050171:Dyslipidemias / Q000097:blood / Q000201:enzymology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000201:enzymology* / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006973:Hypertension / Q000201:enzymology / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008562:Membrane Glycoproteins / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D009765:Obesity / Q000097:blood / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D018384:Oxidative Stress / Q000187:drug effects; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism*; D013997:Time Factors; D046509:Tissue Culture Techniques; D014664:Vasodilation; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D000975:Antioxidants; D001786:Blood Glucose; D004791:Enzyme Inhibitors; D007328:Insulin; D008562:Membrane Glycoproteins; D017382:Reactive Oxygen Species; D014665:Vasodilator Agents; D052250:Nitric Oxide Synthase Type III; C496315:Nos3 protein, mouse; C488842:Cybb protein, mouse; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; D011972:Receptor, Insulin; D051057:Proto-Oncogene Proteins c-akt; C535148:Mapk1 protein, mouse; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3
keywords: NADPH oxidase; Nox2 inhibitor; ageing; endothelial dysfunction; insulin resistance; obesity; oxidative stress
references: Circulation. 2009 Oct 20;120(16):1616-22
references: 19805647
references: J Pharmacol Sci. 2009 Nov;111(3):260-8
references: 19881226
references: Circ Res. 2009 May 8;104(9):1085-94
references: 19342603
references: J Vasc Res. 2011;48(4):275-84
references: 21273782
references: Br J Pharmacol. 2010 Aug;160(7):1573-6
references: 20649560
references: Circ Res. 2002 Feb 8;90(2):143-50
references: 11834706
references: J Clin Invest. 2004 Dec;114(12):1752-61
references: 15599400
references: Endocr Rev. 2006 May;27(3):242-59
references: 16492903
references: Am J Physiol Lung Cell Mol Physiol. 2008 Nov;295(5):L727-32
references: 18723759
references: Diabetes. 2005 Apr;54(4):1082-9
references: 15793247
references: Am J Med. 2007 Mar;120(3):242-50
references: 17349447
references: Hypertension. 2008 Feb;51(2):211-7
references: 18086956
references: Mol Cell Biol. 2005 Mar;25(6):2320-30
references: 15743827
references: Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1633-40
references: 15772334
references: FEBS J. 2010 Dec;277(24):5061-71
references: 21073655
references: Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1014-30
references: 15475499
references: Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1488-96
references: 22460559
references: Diabetes. 2004 Oct;53(10):2645-52
references: 15448096
references: Circulation. 2004 Mar 16;109(10):1307-13
references: 14993144
references: J Biol Chem. 2002 May 31;277(22):19952-60
references: 11893732
references: Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H164-72
references: 21551274
references: Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E392-404
references: 23233541
references: Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1982-8
references: 18772497
references: BMJ. 2011 Apr 13;342:d1996
references: 21490051
references: Endocr Rev. 2002 Oct;23(5):599-622
references: 12372842
references: Mediators Inflamm. 2010;2010:858735
references: 21403905
references: Circulation. 2007 Feb 6;115(5):627-37
references: 17242275
references: J Am Diet Assoc. 2009 Nov;109(11):1886-95
references: 19857630
references: Br J Pharmacol. 2010 Aug;160(7):1577-9
references: 20649561
references: Circ Res. 2001 Feb 2;88(2):E14-22
references: 11157681
references: Cell. 2007 Oct 19;131(2):242-56
references: 17956727
references: Am J Physiol Regul Integr Comp Physiol. 2003 Aug;285(2):R277-97
references: 12855411
references: Diabetes. 2009 Oct;58(10):2238-45
references: 19581418
references: Biochem Biophys Res Commun. 2005 Dec 9;338(1):677-86
references: 16157295
references: Free Radic Biol Med. 2004 Jul 1;37(1):115-23
references: 15183199
references: J Biol Chem. 2010 Dec 17;285(51):40104-13
references: 20940302
references: Diabetes. 2013 Jun;62(6):2130-4
references: 23349484
references: Nat Rev Drug Discov. 2011 Jun;10(6):453-71
references: 21629295
references: Diabetes. 2012 Nov;61(11):2842-50
references: 22933115
references: Hypertension. 2008 Feb;51(2):172-4
references: 18086948
references: Clin Chem Lab Med. 2007;45(10):1319-25
references: 17727314
references: Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1651-6
references: 19608974
references: J Clin Invest. 2003 Dec;112(12):1796-808
references: 14679176
references: Br J Med Med Res. 2012 May 30;2(3):413-423
references: 22905340
references: Diabetes. 2011 Oct;60(10):2474-83
references: 21911747